Correlation Between FormPipe Software and Newbury Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both FormPipe Software and Newbury Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FormPipe Software and Newbury Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between FormPipe Software AB and Newbury Pharmaceuticals AB, you can compare the effects of market volatilities on FormPipe Software and Newbury Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FormPipe Software with a short position of Newbury Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of FormPipe Software and Newbury Pharmaceuticals.

Diversification Opportunities for FormPipe Software and Newbury Pharmaceuticals

-0.21
  Correlation Coefficient

Very good diversification

The 3 months correlation between FormPipe and Newbury is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding FormPipe Software AB and Newbury Pharmaceuticals AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Newbury Pharmaceuticals and FormPipe Software is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FormPipe Software AB are associated (or correlated) with Newbury Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Newbury Pharmaceuticals has no effect on the direction of FormPipe Software i.e., FormPipe Software and Newbury Pharmaceuticals go up and down completely randomly.

Pair Corralation between FormPipe Software and Newbury Pharmaceuticals

Assuming the 90 days trading horizon FormPipe Software AB is expected to generate 0.63 times more return on investment than Newbury Pharmaceuticals. However, FormPipe Software AB is 1.6 times less risky than Newbury Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Newbury Pharmaceuticals AB is currently generating about -0.01 per unit of risk. If you would invest  1,963  in FormPipe Software AB on September 12, 2024 and sell it today you would earn a total of  437.00  from holding FormPipe Software AB or generate 22.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

FormPipe Software AB  vs.  Newbury Pharmaceuticals AB

 Performance 
       Timeline  
FormPipe Software 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days FormPipe Software AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Newbury Pharmaceuticals 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Newbury Pharmaceuticals AB are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Newbury Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

FormPipe Software and Newbury Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with FormPipe Software and Newbury Pharmaceuticals

The main advantage of trading using opposite FormPipe Software and Newbury Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FormPipe Software position performs unexpectedly, Newbury Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Newbury Pharmaceuticals will offset losses from the drop in Newbury Pharmaceuticals' long position.
The idea behind FormPipe Software AB and Newbury Pharmaceuticals AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bonds Directory
Find actively traded corporate debentures issued by US companies
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets